Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-Host Disease (GVHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06321003
What this trial is testing

SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography

Who this might be right for
Oral Squamous Cell CarcinomaOral Potentially Malignant DisorderOral Leukoplakia+9 more
University of Palermo 200
Not applicableLooking for participantsNCT07297303
What this trial is testing

Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients

Who this might be right for
Bronchiolitis Obliterable Syndrome
National Taiwan University Hospital 600
Not applicableStudy completedNCT07784452
What this trial is testing

Comparing Hepatitis B Vaccination Schedules in Patients on Hemodialysis

Who this might be right for
Hepatitis BESRD (End Stage Renal Disease)Kidney Failure+1 more
Jinnah Hospital 104
Not applicableStudy completedNCT05238155
What this trial is testing

Evaluation of the Impact of Reduced Immunosuppression

Who this might be right for
Graft Vs Host Disease
Methodist Health System 100
Large-scale testing (Phase 3)Ended earlyNCT00967343
What this trial is testing

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Myeloid LeukemiaLymphoblastic LeukemiaLymphoma+3 more
Kiadis Pharma 40
Post-approval studies (Phase 4)Study completedNCT00202189
What this trial is testing

Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Queen's University 4
Large-scale testing (Phase 3)Study completedNCT05166967
What this trial is testing

Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 204
Not applicableActive Not RecruitingNCT05250037
What this trial is testing

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

Who this might be right for
Bronchiolitis Obliterans SyndromeHematopoietic and Lymphoid Cell Neoplasm
Fred Hutchinson Cancer Center 261
Not applicableUnknownNCT00450268
What this trial is testing

Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft Versus Host Disease
Technische Universität Dresden 50
Testing effectiveness (Phase 2)Study completedNCT02588339
What this trial is testing

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Who this might be right for
Graft Versus Host DiseaseGVHD
H. Lee Moffitt Cancer Center and Research Institute 42
Early research (Phase 1)WithdrawnNCT02528877
What this trial is testing

Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

Who this might be right for
Acute Myeloid Leukemia in RemissionPrimary MyelofibrosisPrimary Myelofibrosis, Prefibrotic Stage+2 more
City of Hope Medical Center
Post-approval studies (Phase 4)Active Not RecruitingNCT03229200
What this trial is testing

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Who this might be right for
Lymphoma, B-CellLymphoma, Non-HodgkinLeukemia, B-cell+2 more
Pharmacyclics Switzerland GmbH 297
Not applicableStudy completedNCT05544448
What this trial is testing

In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases

Who this might be right for
Autoimmune DiseasesInflammatory DiseaseAcquired Bone Marrow Aplasia+8 more
Assistance Publique - Hôpitaux de Paris 67
Not applicableWithdrawnNCT01988701
What this trial is testing

Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host DiseaseHematopoietic/Lymphoid Cancer
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00815919
What this trial is testing

Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Dana-Farber Cancer Institute 22
Post-approval studies (Phase 4)Study completedNCT02518464
What this trial is testing

Ticagrelor Therapy for RefrACTORy Migraine Study

Who this might be right for
MigraineHeadacheMigraine Headache
Columbia University 40
Testing effectiveness (Phase 2)Ended earlyNCT03701698
What this trial is testing

Ruxolitinib and Steroid As First Line Therapy for Acute GVHD

Who this might be right for
Acute GVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 1
Very early researchNot Yet RecruitingNCT06952114
What this trial is testing

Stem Cells Lenses in the coGVHD Subjects

Who this might be right for
Chronic Ocular Graft-versus-host Disease
Guangdong ProCapZoom Biosciences Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT01349101
What this trial is testing

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT06388564
What this trial is testing

Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host-disease
Incyte Corporation 130
Next Page